Medicine & Life Sciences
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
Activated Protein C Resistance
Anticoagulants
Arachidonic Acid
Atherosclerosis
betrixaban
Blood Platelets
Blood Vessels
BM 567
Carbonic Anhydrase Inhibitors
Carbonic Anhydrase IX
Carbonic Anhydrases
Cyclooxygenase 2 Inhibitors
Dabigatran
Dasatinib
eculizumab
Epoprostenol
Extracellular Vesicles
Hemorrhage
Hemostasis
Heparin
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
N-terbutyl-N'-(2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl)urea
Nanoparticles
Nanostructures
nimesulide
Paroxysmal Hemoglobinuria
Pharmaceutical Preparations
Pharmacology
Platelet Aggregation
ponatinib
Prostaglandin H2 Receptors Thromboxane A2
Prostaglandin-Endoperoxide Synthases
Protein-Tyrosine Kinases
Prothrombin Time
Rivaroxaban
SARS Virus
Sulfonamides
Swine
terbogrel
Therapeutics
Thrombin
Thrombosis
Thromboxane A2
Thromboxane Receptors
Thromboxanes
Torsemide
Urea
Vitamin K
Chemical Compounds
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
Agglomeration
Anticoagulants
Arachidonic Acid
Assays
Blood
BM 567
Carbonic Anhydrase Inhibitors
Carbonic Anhydrases
Cells
Chemical activation
Chromogenics
Coagulation
Crystal structure
Cyclooxygenase 2 Inhibitors
Dabigatran
Derivatives
Electronic structure
Epoprostenol
Heparin
Hydrogen bonds
Mass spectrometry
Modulators
Molecular modeling
Molecules
Muscle
N-terbutyl-N'-(2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl)urea
N-tert-butyl-N'-(2-(3-'-methylphenylamino)-5-nitrobenzenesulfonyl)urea
Nanoparticles
Nanostructured materials
Pharmaceutical Preparations
Plasmas
Platelets
Prostaglandin H2 Receptors Thromboxane A2
Prostaglandins
Protein C
Rats
silicon carbide
Silver nanoparticles
Surgery
terbogrel
Thrombin
Thromboxane A2
Thromboxane Receptors
Thromboxanes
Torsemide
Toxicity
Tumors
Urea
X rays
